Karola Rittner

Person

Strasbourg, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Oncolytic virus for expression of immune checkpoint modulators
- Patent number 11,779,619
- Issue date Oct 10, 2023
- Transgene S.A.
- Nathalie Silvestre
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oncolytic virus for expression of immune checkpoint modulators
- Patent number 10,555,981
- Issue date Feb 11, 2020
- Transgene S.A.
- Nathalie Silvestre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AAV DNA comprising helper virus sequences
- Patent number 7,148,341
- Issue date Dec 12, 2006
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Jürgen Kleinschmidt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Viral vectors and line for gene therapy
- Patent number 6,204,060
- Issue date Mar 20, 2001
- Transgene S.A.
- Majid Mehtali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
- Publication number 20240024437
- Publication date Jan 25, 2024
- Transgene S.A.
- Philippe Slos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Parapoxvirus vectors
- Publication number 20210000937
- Publication date Jan 7, 2021
- TRANSGENE
- Karola RITTNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
- Publication number 20200197457
- Publication date Jun 25, 2020
- Transgene S.A.
- Nathalie Silvestre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH CPG TLR9 LIGAND
- Publication number 20190134190
- Publication date May 9, 2019
- Transgene S.A.
- Karola Rittner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
- Publication number 20180028626
- Publication date Feb 1, 2018
- Transgene S.A.
- Philippe Slos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
- Publication number 20170157188
- Publication date Jun 8, 2017
- Transgene S.A.
- Nathalie Silvestre
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACT...
- Publication number 20110287089
- Publication date Nov 24, 2011
- Karola Rittner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of non-complexing peptides for the preparation of a composition...
- Publication number 20040132188
- Publication date Jul 8, 2004
- Karola Rittner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Viral vectors and line for gene therapy
- Publication number 20030203488
- Publication date Oct 30, 2003
- Majid Mehtali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AAV DNA comprising helper virus sequences
- Publication number 20020076801
- Publication date Jun 20, 2002
- Krebsforschungszentrum and Transgene S.A.
- Jurgen Kleinschmidt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Complex for transferring an anionic substance of interest into a cell
- Publication number 20020055174
- Publication date May 9, 2002
- Karola Rittner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Karola Rittner

Person

Patents Grantslast 30 patents

Oncolytic virus for expression of immune checkpoint modulators

Oncolytic virus for expression of immune checkpoint modulators

AAV DNA comprising helper virus sequences

Viral vectors and line for gene therapy

Patents Applicationslast 30 patents

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

Parapoxvirus vectors

ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS

COMBINATION THERAPY WITH CPG TLR9 LIGAND

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS

USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACT...

Use of non-complexing peptides for the preparation of a composition...

Viral vectors and line for gene therapy

AAV DNA comprising helper virus sequences

Complex for transferring an anionic substance of interest into a cell